0.397
price down icon0.95%   -0.0038
after-market After Hours: .38 -0.017 -4.28%
loading
Azitra Inc stock is traded at $0.397, with a volume of 356.13K. It is down -0.95% in the last 24 hours and down -42.46% over the past month. Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
See More
Previous Close:
$0.4008
Open:
$0.384
24h Volume:
356.13K
Relative Volume:
0.08
Market Cap:
$1.40M
Revenue:
$1.27M
Net Income/Loss:
$-11.28M
P/E Ratio:
-0.0177
EPS:
-22.4496
Net Cash Flow:
$-10.46M
1W Performance:
-15.66%
1M Performance:
-42.46%
6M Performance:
+34.58%
1Y Performance:
-23.95%
1-Day Range:
Value
$0.375
$0.4005
1-Week Range:
Value
$0.3501
$0.4711
52-Week Range:
Value
$0.1305
$1.40

Azitra Inc Stock (AZTR) Company Profile

Name
Name
Azitra Inc
Name
Phone
203 646 6446
Name
Address
21 Business Park Drive, Branford
Name
Employee
10
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
AZTR's Discussions on Twitter

Compare AZTR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
AZTR
Azitra Inc
0.397 2.17M 1.27M -11.28M -10.46M -22.45
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
429.22 106.87B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
674.55 68.81B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
451.95 58.35B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
889.64 53.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
193.69 40.93B 447.02M -1.18B -906.14M -6.1812

Azitra Inc Stock (AZTR) Latest News

pulisher
02:08 AM

Ranking Azitra Inc. among high performing stocks via toolsProfit Target & Consistent Profit Alerts - newser.com

02:08 AM
pulisher
01:28 AM

Can Azitra Inc. stock hit analyst price targetsJuly 2025 Setups & High Accuracy Investment Signals - newser.com

01:28 AM
pulisher
07:40 AM

Why pension funds invest in Azitra Inc stockTrade Volume Summary & Entry Point Confirmation Signals - newser.com

07:40 AM
pulisher
05:12 AM

Should I hold or sell Azitra Inc. stock in 2025Portfolio Risk Report & Stepwise Entry and Exit Trade Signals - newser.com

05:12 AM
pulisher
Nov 10, 2025

Is Azitra Inc. stock a safe buy before earningsWeekly Earnings Recap & Real-Time Market Sentiment Alerts - newser.com

Nov 10, 2025
pulisher
Nov 10, 2025

Can Azitra Inc stock attract ESG investments2025 Winners & Losers & Growth Focused Stock Pick Reports - newser.com

Nov 10, 2025
pulisher
Nov 10, 2025

Healthy Upside Potential: Azitra Inc (AZTR) - setenews.com

Nov 10, 2025
pulisher
Nov 10, 2025

Is Azitra Inc. stock supported by strong fundamentalsMarket Sentiment Review & Safe Capital Allocation Plans - newser.com

Nov 10, 2025
pulisher
Nov 10, 2025

How Azitra Inc stock trades in high volatilityIPO Watch & Target Return Focused Stock Picks - newser.com

Nov 10, 2025
pulisher
Nov 09, 2025

Understanding Azitra Inc.’s price movementQuarterly Market Summary & Daily Price Action Insights - newser.com

Nov 09, 2025
pulisher
Nov 07, 2025

Azitra says report of $44M registered direct offering is false - TipRanks

Nov 07, 2025
pulisher
Nov 07, 2025

Azitra denies false report of $44 million registered direct offering By Investing.com - Investing.com Nigeria

Nov 07, 2025
pulisher
Nov 07, 2025

Azitra, Inc. addresses false report regarding sale of securities - MarketScreener

Nov 07, 2025
pulisher
Nov 07, 2025

Azitra denies false report of $44 million registered direct offering - Investing.com

Nov 07, 2025
pulisher
Nov 07, 2025

Azitra (NYSE American: AZTR) says $44M registered direct offering report is false - Stock Titan

Nov 07, 2025
pulisher
Nov 07, 2025

Why Azitra Inc stock stays on buy listsMarket Rally & Free Safe Capital Growth Stock Tips - newser.com

Nov 07, 2025
pulisher
Nov 06, 2025

Can Azitra Inc. hit a new high this monthDip Buying & Free Fast Entry Momentum Trade Alerts - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Is Azitra Inc. stock entering bullish territoryWeekly Profit Summary & Low Risk High Win Rate Picks - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Azitra Inc Stock Analysis and ForecastRisk Management Strategies & Discover Stocks Experts Are Watching - earlytimes.in

Nov 06, 2025
pulisher
Nov 06, 2025

How Azitra Inc. stock compares to industry benchmarks2025 Historical Comparison & Daily Entry Point Trade Alerts - newser.com

Nov 06, 2025
pulisher
Nov 05, 2025

Can Azitra Inc stock stage a strong rebound this quarter2025 Trading Volume Trends & Weekly High Potential Alerts - newser.com

Nov 05, 2025

Azitra Inc Stock (AZTR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$38.96
price up icon 1.09%
$30.31
price up icon 4.30%
$108.16
price up icon 2.07%
$108.65
price up icon 3.41%
biotechnology ONC
$343.65
price up icon 4.39%
$193.69
price up icon 0.92%
Cap:     |  Volume (24h):